Skip to main content
Premium Trial:

Request an Annual Quote

Paul Kelly, Bernd R. Seizinger, Ming Tsuang


Paul Kelly has been appointed CEO of Orchid Biosciences, filling a position that has been left vacant since Dale Pfost resigned as CEO in December 2002.

Kelly comes to Orchid from software company OmniViz, where he was CEO. He was previously a co-founder and CEO of Gemini Genomics, a UK-based population genetics firm that was acquired by Sequenom in 2001.

Bernd R. Seizinger, CEO and president of GPC Biotech, has been appointed to the board of directors at Heidelberg, Germany-based chemical genomics company Graffinity Pharmaceuticals.

Seizinger has held his executive position at Martinsried, Germany-based GPC Biotech since 1998. Prior to that, he was executive vice president and chief scientific officer at Genome Therapeutics. He also has worked in senior positions at Bristol-Myers Squibb’s Pharmaceutical Research Institute, and as an associate professor of neuroscience at Harvard Medical School and director of the Molecular Neuro-Oncology Laboratory at Massachusetts General Hospital.

Renowned human geneticist Ming Tsuang has been named director of the University of California San Diego’s new Institute of Behavioral Genomics.

Tsuang is a professor of psychiatry at Harvard Medical School and is director of the Harvard Institute of Psychiatric Epidemiology and Genetics and the Harvard Department of Psychiatry at the Massachusetts Mental Health Center.


Filed under

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.